Connection

David Potter to Antihypertensive Agents

This is a "connection" page, showing publications David Potter has written about Antihypertensive Agents.
Connection Strength

0.435
  1. Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine. J Ocul Pharmacol Ther. 1997 Dec; 13(6):489-96.
    View in: PubMed
    Score: 0.108
  2. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: role of cGMP. Pharmacology. 1997 Oct; 55(4):211-6.
    View in: PubMed
    Score: 0.107
  3. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996 Sep; 15(9):943-50.
    View in: PubMed
    Score: 0.099
  4. Alpha-2 adrenoceptor mediated changes in aqueous dynamics: effect of pertussis toxin. Exp Eye Res. 1994 Jun; 58(6):729-36.
    View in: PubMed
    Score: 0.085
  5. Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics. Curr Eye Res. 2001 May; 22(5):358-66.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.